Biological Data Analysis

At Profacgen, our biological data analysis services transform complex biological, pharmaceutical, and clinical datasets into actionable insights, enabling researchers to accelerate discovery cycles without requiring expertise in programming, statistics, or modeling.

Biologists are stepping up their efforts in understanding biological processes by using a variety of experimental and bioinformatics methods. This has resulted in a flood of biological and clinical data, which can be overwhelming for researchers to handle without appropriate data processing and analysis tools, especially when there is a lack of training or no knowledge of programming, statistics, and modeling. Custom data analysis services have become increasingly important in biosciences and can certainly help accelerate the research cycle.

Profacgen provides comprehensive data analysis services for discovering new knowledge from various types of biological data. Our team has created efficient data analysis pipelines and combines mathematics, statistics, and programming to conduct the requested analyses for our customers' specific technological or biological research questions. We are also experienced with state-of-the-art data mining techniques designed to handle challenging problems where noisy and incomplete data and compute-intensive tasks need to be addressed.

Biological data analysis services for life sciences research

Transforming Biological Data into Biological Insights

Our biological data analysis platform delivers structured, interpretation-ready outputs across the critical dimensions of life sciences research:

Data interpretation: Systematic processing of raw experimental data from genomic, transcriptomic, proteomic, and metabolomic platforms to extract biologically meaningful patterns, correlations, and regulatory relationships. We transform noisy, high-dimensional datasets into coherent narratives aligned with your research objectives
Biomarker discovery: Exploitation of diverse data types from ChIP-Seq, RNA-Seq, miRNA sequencing, 4C-Seq, microarray, and mass spectrometry experiments for rapid identification and validation of diagnostic, prognostic, and predictive biomarkers. Our pipelines integrate statistical significance testing with biological relevance filtering
Functional analysis: Systematic reconstruction and analysis of biological pathways and networks from observed data using graph-theoretic approaches. Exploration of network behavior, integration of prior knowledge, and differential analysis in the context of integrated experimental data on a global scale provide effective means for analyzing complex systems with great potential for biomedical applications
Biological hypothesis generation: Data-driven identification of novel regulatory mechanisms, gene-phenotype associations, and therapeutic targets. Our analyses are designed not merely to describe data but to generate testable hypotheses that advance experimental programs

Our Analysis Capabilities

Profacgen offers specialized analysis services across major omics domains, each optimized for the specific data characteristics and biological questions of the platform:

Genomics Data Analysis

Comprehensive processing and interpretation of DNA-level data to uncover genetic variation, regulatory elements, and genome architecture.

Variant calling and annotation: SNP, indel, and structural variant detection from whole-genome and exome sequencing
ChIP-Seq analysis: peak calling, motif discovery, and transcription factor binding site identification
Epigenomic profiling: DNA methylation, histone modification, and chromatin accessibility assessment
Genome assembly and comparative genomics for non-model organisms

Transcriptomics Data Analysis

Quantitative and qualitative analysis of RNA-level data to map gene expression landscapes and regulatory networks.

RNA-Seq differential expression analysis: DESeq2, edgeR, and limma-based statistical frameworks
Alternative splicing and isoform quantification
Single-cell RNA-Seq: clustering, trajectory inference, and cell-type annotation
miRNA and small RNA profiling for post-transcriptional regulation studies

Proteomics Data Analysis

Quantitative and structural analysis of protein-level data to characterize expression, modification, and interaction networks.

Mass spectrometry-based protein identification and quantification: label-free and TMT/iTRAQ workflows
Post-translational modification mapping: phosphorylation, ubiquitination, and glycosylation site identification
Protein-protein interaction network reconstruction from affinity purification and proximity labeling data

Multi-Omics Integration

Cross-platform data fusion to capture biological complexity beyond single-omics perspectives.

Correlation and co-expression network analysis across genomic, transcriptomic, and proteomic layers
Multi-omics factor analysis and pathway-level integration
Patient stratification and subtype discovery from integrated clinical and molecular profiles

Bioinformatics Workflows

Our analysis pipelines are built on rigorous, reproducible bioinformatics workflows that ensure data quality and analytical robustness:

Bioinformatics workflow

Quality Control: Systematic assessment of raw data quality, including sequencing depth, coverage uniformity, batch effect detection, and technical artifact identification. We test the impact of artifacts and limit instrument-based biases before downstream analysis
Differential Analysis: Statistical testing, regression, clustering, and classification methods applied to identify significant changes across experimental conditions. We employ resampling, quality control, and outlier detection to validate the robustness and reproducibility of your experiments
Functional Annotation: Gene ontology enrichment, pathway mapping, and functional category analysis to assign biological meaning to differentially expressed or modified features. We integrate prior knowledge databases to contextualize findings
Pathway Analysis: Graph-theoretic and topology-based approaches to reconstruct and analyze biological networks from observed data. Differential analysis in the context of integrated experimental data on a global scale provides effective means for analyzing complex systems with great potential for biomedical applications

Applications

Our biological data analysis services support a broad spectrum of applications across pharmaceutical development and fundamental research:

Target Discovery: Integration of genomic, transcriptomic, and proteomic data to identify novel therapeutic targets, validate target-disease associations, and predict druggability. Our pipelines mine public and proprietary datasets to prioritize targets with strong biological rationale
Biomarker Identification: Exploitation of a wide range of data types from ChIP-Seq, RNA-Seq, miRNA sequencing, 4C-Seq, microarray, and mass spectrometry experiments for the rapid identification and validation of diagnostic, prognostic, and predictive biomarkers. Statistical methods ensure robust biomarker selection with controlled false discovery rates
Disease Mechanism Research: Reconstruction of disease-associated pathways and networks from patient-derived omics data. We identify dysregulated modules, driver mutations, and causal regulatory relationships to elucidate pathophysiological mechanisms
Drug Development: Pharmacogenomic analysis, drug response prediction, and mechanism-of-action dissection from preclinical and clinical datasets. We support biomarker-driven patient stratification for precision clinical trial design

Deliverables

Profacgen provides structured, publication-ready documentation aligned with your analytical requirements:

Parameter	Description
Processed Datasets	Quality-controlled, normalized, and annotated data matrices with metadata documentation, ready for downstream analysis or deposition in public repositories
Statistical Reports	Comprehensive project reports with detailed analysis procedures, statistical test results, significance thresholds, effect sizes, and multiple testing correction methods
Biological Interpretation	Expert-curated biological interpretation of analytical results, including pathway enrichment summaries, network visualizations, and hypothesis generation for follow-up experiments
Visualization Outputs	Publication-quality figures: heatmaps, volcano plots, PCA/t-SNE/UMAP embeddings, network diagrams, and phylogenetic trees prepared according to journal standards
Technical Consultation	Expert consultation on experimental design, data interpretation, and biological significance, with presentation of results and preparation of figures for publications

Request a quote

Why Choose Profacgen

State-of-the-Art Tools: We deploy cutting-edge software and algorithms to analyze and interpret life sciences data, ensuring our pipelines incorporate the latest methodological advances.
Comprehensive Project Reports: Each project includes a detailed analysis report with procedures, statistical outputs, and biological interpretation, ensuring full transparency and reproducibility.
Expert Consultation: Our interdisciplinary team is available for technical consultation and experimental design, helping you optimize data generation before analysis.
Publication Support: We present results and prepare publication-ready figures, validating the robustness and reproducibility of your experiments for peer review.
Artifact Control: We test the impact of technical artifacts and limit instrument-based biases, ensuring biological conclusions are grounded in genuine signal rather than noise.

Representative Program Scenarios

Scenario 1: Multi-Omics Biomarker Discovery for Oncology

Program Context:

A pharmaceutical client required identification of predictive biomarkers for response to a novel kinase inhibitor in solid tumors. Single-omics analyses had yielded inconsistent results, and the team sought an integrated multi-omics approach to identify robust, clinically actionable signatures.

Objective:

To integrate whole-exome sequencing, RNA-Seq, and proteomic data from preclinical tumor models and patient-derived xenografts to identify a multi-omics biomarker signature predictive of drug response.

Approach:

Profacgen processed raw sequencing data through standardized QC pipelines, performed differential expression and variant analysis, and integrated proteomic quantification by label-free mass spectrometry. Multi-omics factor analysis identified co-regulated gene-protein modules, and machine learning classifiers were trained on responder vs. non-responder profiles. Pathway enrichment and network analysis contextualized the biomarker signature.

Outcome:

A 12-feature multi-omics signature was identified with 88% predictive accuracy in cross-validation. The signature encompassed a mutation in the drug target, compensatory pathway upregulation, and a secreted protein biomarker measurable in serum. The client progressed to a biomarker-stratified clinical trial design.

Scenario 2: Single-Cell Transcriptomic Analysis of Immune Microenvironment

Program Context:

An immunotherapy program required characterization of the tumor immune microenvironment to understand resistance mechanisms to checkpoint inhibitors. Bulk RNA-Seq had provided population-averaged signals but failed to resolve rare immune cell subsets and their functional states.

Objective:

To execute single-cell RNA-Seq analysis of tumor-infiltrating immune cells from responder and non-responder patients, identifying cell-type-specific gene expression programs and intercellular communication networks associated with therapeutic response.

Approach:

Profacgen processed 10x Genomics single-cell data through Cell Ranger, performed quality filtering and doublet removal, and executed clustering and cell-type annotation using reference-based and de novo approaches. Trajectory inference mapped differentiation paths, and ligand-receptor analysis reconstructed intercellular communication networks. Differential state analysis identified response-associated programs in T-cell and myeloid compartments.

Outcome:

A rare exhausted T-cell subset with unique transcriptional signature was identified as enriched in non-responders. Ligand-receptor analysis revealed a tumor cell-macrophage signaling axis driving immunosuppression. The findings supported a combination therapy strategy targeting the identified axis, which entered preclinical validation.

Get a Project Assessment

Frequently Asked Questions (FAQs)

Q: What types of biological data can Profacgen analyze?

A: We analyze data from genomics (whole-genome, exome, ChIP-Seq), transcriptomics (RNA-Seq, single-cell RNA-Seq, microarray, miRNA-Seq), proteomics (mass spectrometry-based identification and quantification), metabolomics, and multi-omics integration. We also support image analysis from optical and electron microscopy, and structural biology data from X-ray crystallography, NMR, and cryo-EM.

Q: Do I need programming or statistical expertise to use your services?

A: No. Our services are designed for researchers without expertise in programming, statistics, or modeling. We handle all computational aspects, from data processing to biological interpretation, and deliver results in accessible formats with expert consultation. Individual analysis tasks are defined in close collaboration with you within a controlled budget.

Q: How do you ensure data quality and reproducibility?

A: We implement rigorous quality control at every stage: raw data assessment, batch effect detection, outlier identification, and technical artifact correction. We employ standardized pipelines with version-controlled software, document all parameters and thresholds, and validate robustness through resampling and cross-validation. Results are delivered in favored formats and are presented and explicated personally.

Q: Can you handle large-scale or compute-intensive datasets?

A: Yes. Our bioinformatics platform includes a parallel computer cluster (CPU: 2×12, RAM: 128G) with continuous expansion to meet growing computational demands. We are experienced with state-of-the-art data mining techniques designed to handle challenging problems where noisy and incomplete data and compute-intensive tasks need to be addressed.

Q: What deliverables will I receive?

A: You will receive processed datasets, comprehensive statistical reports with detailed analysis procedures, expert biological interpretation, publication-quality figures, and technical consultation. Results are delivered in your favored formats and are presented and explicated personally. We also support preparation of figures for publications.

Q: Can you support longitudinal or time-course analyses?

A: Yes. We design and execute time-series analyses for longitudinal studies, including trajectory inference, temporal clustering, and dynamic network modeling. These approaches are particularly valuable for developmental studies, drug response monitoring, and disease progression tracking. We build and maintain research data workflows to help increase reproducibility and scaling up of complex data analysis tasks.